key: cord-0683038-87byu6sj authors: Das, Kirsten J. H.; Fuerst, Megan; Brown, Ciara; Lesko, Jennifer title: Use of postpartum contraception during coronavirus disease 2019 (COVID‐19): A retrospective cohort study date: 2021-07-13 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13805 sha: 8d10be9ba2e5aad6086c6984b3f92a5d0fc3e207 doc_id: 683038 cord_uid: 87byu6sj OBJECTIVE: To assess how use of postpartum contraception (PPC) changed during the COVID‐19 public health emergency. METHODS: Billing and coding data from a single urban institution (n = 1797) were used to compare use of PPC in patients who delivered from March to June 2020 (COVID Cohort, n = 927) and from March to June 2019 (Comparison Cohort, n = 895). χ(2) and multivariable logistic regression models assessed relationships between cohorts, use of contraception, and interactions with postpartum visits and race/ethnicity. RESULTS: In the COVID Cohort, 585 women (64%) attended postpartum visits (n = 488, 83.4%, via telemedicine) compared to 660 (74.7%, in‐person) in the Comparison Cohort (P < 0.01). Total use of PPC remained similar: 30.4% (n = 261) in the COVID Cohort and 29.6% (n = 278) in the Comparison Cohort (P = 0.69). Compared to in‐person visits in the Comparison Cohort, telemedicine visits in the COVID Cohort had similar odds of insertion of long‐acting reversible contraception (LARC) (adjusted odds ratio [aOR] 1.13, 95% confidence interval [CI] 0.78–1.6), but higher odds of inpatient insertion (aOR 6.4, 95% CI 1.7–24.9). Black patients compared to white patients were more likely to initiate inpatient LARC (aOR 7.29, 95% CI 1.81–29.4) compared to the Comparison Cohort (aOR 3.63, 95% CI 0.29–46.19). CONCLUSION: Use of PPC remained similar during COVID‐19 with a decrease of in‐person postpartum visits, new adoption of postpartum telemedicine visits, and an increase in inpatient insertion of LARC with higher odds of inpatient placement among black patients. IPP contraception counseling must be balanced with patientcentered counseling and autonomy, including the role of bias. States has long-favored educated, white, able-bodied individuals over other groups, with the well-established role of systemic racism and implicit bias. 4, 5 In addition to the historical context of reproductive coercion, healthcare providers are also more likely to recommend placement of long-acting reversible contraception (LARC) to black and Hispanic patients compared to white patients. 6 Due to the COVID-19 pandemic, a national public health emergency (PHE) was declared, 7 and to avoid transmission, physical elective and non-urgent outpatient visits were postponed. 8, 9 Thus, it was recommended to convert postpartum visits to telemedicine and insert IPP LARC. [10] [11] [12] [13] [14] [15] Several studies articulated the potential impact to the utilization of contraception and telemedicine during the COVID-19 PHE. 16 One such survey found that 12% of obstetricians and gynecologists (OBGYNs) before March 2020 utilized some telemedicine versus 84% in June 2020, although in June 2020 only 9% of OBGYNs were using telemedicine for over 50% of their visits. 17 A study conducted in June 2020 found that 34% of women delayed or decreased pregnancy plans due to the COVID-19 pandemic, with the greatest change in black and Hispanic, queer, and low-income populations. 19 It is believed that there are no studies published to date evaluating the use of postpartum contraception during the COVID-19 PHE. [17] [18] [19] [20] Thus, the use of postpartum contraception during the COVID-19 PHE was evaluated and the role of in-person and newly implemented telemedicine postpartum visits with the use of inpatient placement of LARC was assessed. 21 In addition, the differences in the use of postpartum contraception by race and ethnicity were explored. It was hypothesized that usage of LARC would decrease in the setting of less in-person postpartum visits. The present study was a retrospective cohort study investigating the use of postpartum contraception at a single urban academic medical center. All patients were included who delivered from March 1 to June 15, 2020 (COVID Cohort), when a stay-at-home order with limited reopening was in effect, compared to all women who delivered from March 1 to June 15, 2019 (Comparison Cohort). Data were included from 12 weeks after delivery (postpartum) and 9 months before (prenatal). To obtain the analysis sample, non-live births were excluded (n = 25). A power analysis was performed to determine the minimum sample size needed to detect a 15% change in overall use of contraception (alpha of 0.05, beta of 0.80). Billing and coding data from electronic health records (EHR) were used. Because the inpatient EHR is a different software system from the outpatient EHR, the two datasets were combined using patient medical record number, name, and date of birth. A manual chart review was then conducted of 10% of the data to confirm an accuracy of 90% or greater of use of contraception, postpartum visit date, and site of care. Covariates included sociodemographic factors including age, race/ethnicity, marital status, and insurance status. The Washington D.C. SocioNeeds Index was used to identify home zip codes into the two lowest income quintiles. 22 Common International Classification of Diseases, Tenth Revision (ICD-10) codes related to pregnancy, childbirth, and puerperium (Appendix A) were identified to adjust for common complications of pregnancy (e.g. hypertension or hemorrhage). Data of postpartum visits from the COVID Cohort were obtained from the EHR and differentiated into in-person and telemedicine visits within 12 weeks after delivery. Contraception procedure, diagnosis, and dispensing codes were used to identify forms of postpartum contraception. LARC included implant and intrauterine devices, and short-acting reversible contraception (SARC) included pills, patches, shots, and vaginal rings. Appendix A lists the Current Procedural Terminology (CPT), ICD-10, and dispensing codes. Frequency and percentage were used to describe patient demographics, pregnancy-related factors, and utilization of postpartum contraception. χ 2 tests and two-sided t-tests were used to compare characteristics in the COVID Cohort with those in the Comparison Cohort. Multivariable logistic regression models were used to compare the odds of using various forms of contraception. Covariates of interest were selected based on previous research 23 and for bivariate associations (P < 0.1). At this institution, contraception counseling was typically performed during the prenatal visits in the third trimester, postpartum before discharge, and during the postpartum visit. All women had access to inpatient placement of LARC if desired and no policy change regarding contraception was implemented during the study period. Postpartum telemedicine visits were not available before the COVID-19 PHE but were routinely offered to all patients during the COVID-19 PHE with in-person visits recommended based on provider discretion and patient preference. Sterilization procedures after a vaginal delivery were considered elective and postponed during the PHE but were still performed if during a cesarean delivery. It was a priori hypothesized that attendance at postpartum visits and site of care would be an effect modifier for the proposed association and tested interaction terms within the various models. Based on the bivariate analysis, showing large racial disparities in the use of contraceptive methods, a secondary analysis was conducted with a dichotomous race variable (i.e. individuals who identified as black compared to those who identified as white). Self-reported race data were extracted from the outpatient EHR Table 4 ). The secondary analysis evaluated use of postpartum contraception by race and ethnicity. Figure 2 displays the frequencies of use of postpartum contraception by race among the COVID and Comparison Cohorts. Table 5 Similar analyses were done for Hispanic versus Non-Hispanic patients; however, the sample of data was inadequately powered to deliver robust results. Given the retrospective design of the present study, data were lim- The COVID-19 PHE changed the location of postpartum visits and thus site of care for the use of contraception; however, overall, patients were still able to obtain placement of LARC, and prescriptions for SARC Values are given as aOR (95% CI). c Outcomes for SARC initiated in the inpatient setting not presented due to insufficient sample size; 0 patients who identified as white were provided SARC in the inpatient setting. American College of Obstetricians and Gynecologists. Committee opinion number 736. Optimizing postpartum care The LARC Program and The American College of Obstetricians and Gynecologists. Immediate Postpartum LARC for Clinicians Doing Deliveries Immediate postpartum insertion of intrauterine device for contraception Inpatient postpartum long-acting reversible contraception: care that promotes reproductive justice Patients' experiences with an immediate postpartum long-acting reversible contraception program. Women's Health Issues Implicit bias in counseling for permanent contraception: historical context and recommendations for counseling Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus. HHS.gov DC Health Regulation and Licensing Administration. Recommendations on Limitations of Elective and Non-urgent Medical and Dental Procedure. 2020 Mayor Bowser Issues Stay-At-Home Order Labor and delivery guidance for COVID-19 Reversible Contraception Availability After Childbirth During The COVID-19 Pandemic | Health Affairs Blog Elective" procedures for women's reproduction during Covid-19 What Family Planning Providers Can Do to Meet Client Needs During COVID-19 | Reproductive Health National Training Center Family planning and abortion services in COVID 19 pandemic Key changes made to telehealth guidelines to boost COVID-19 care How OBGYNs Adapted Provision of Sexual and Reproductive Health Care During the COVID-19 women s-healt h-polic y/issue -brief/ how-obgyn s-adapt ed-provi sion-of-sexua l-and-repro ducti ve-healt h-care-durin g-the-covid -19-pande mic Family Planning Visits During the COVID-19 Pandemic: Phase 1 Results. Society of Family Planning Early Impacts of the COVID-19 Pandemic: Findings from the 2020 Guttmacher Survey of Reproductive Health Experiences. Guttmacher Institute. 2020 Impact of the COVID-19 pandemic on partner relationships and sexual and reproductive health: cross-sectional, online survey study Telehealth interventions to improve obstetric and gynecologic health outcomes ?modul e=indic ators &contr oller =index &actio n=socio needs Factors associated with postpartum use of long-acting reversible contraception Characterization of Medicaid policy for immediate postpartum contraception Implementation of obstetric telehealth during COVID-19 and beyond Use of postpartum contraception during coronavirus disease 2019 (COVID-19): A retrospective cohort study The authors have no conflicts of interest. KJHD: Creation of project idea, submission to institutional review board, design of study, planning of data analysis, review of data analysis, conducted preliminary data analysis, wrote first and final draft of manuscript. MF: Design of initial study plan and subsequent changes, planning of data analysis, conducted data analysis, contributed to multiple drafts of the manuscript. CB: Conducted data analysis and contributed to multiple drafts of the manuscript. JL: Principal investigator, contributed to the initial design and planning phases, reviewed data analysis, and contributed feedback to multiple drafts of the manuscript.